PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based ChemotherapySharlene Gill, Malcolm J. Moore, Yoo‐Joung Ko et al.|Journal of Clinical Oncology|2016Cited by 291
Abstract 3888: Molecular profiling of sequential biopsies in patients with metastatic colorectal cancer identifies genomic alterations that evolve during first-line therapy and could have therapeutic implications: A prospective study to identify molecular mechanisms of clinical resistance (QCROC-01: NCT00984048).Suzan McNamara, Gerald Batist, Benoît Samson et al.|Cancer Research|2015Cited by 0
Prognostic factors associated with short-term survival (STS) in advanced pancreatic cancer (APC): A multicenter analysis from the CHORD consortium.Sakshi Mehta, Brandon M. Meyers, M-J.D.V.B.A.D.C. Cardoso et al.|Journal of Clinical Oncology|2020Cited by 0